Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.4.

  • Cumberland Pharmaceuticals' Equity Ratio rose 2276.48% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year increase of 2276.48%. This contributed to the annual value of 0.3 for FY2024, which is 1647.62% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Equity Ratio of 0.4 as of Q3 2025, which was up 2276.48% from 0.41 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Equity Ratio's 5-year high stood at 0.54 during Q2 2021, with a 5-year trough of 0.3 in Q4 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' median Equity Ratio value was 0.41 (recorded in 2023), while the average stood at 0.41.
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 2301.09% in 2022, then skyrocketed by 2282.76% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Equity Ratio (Quarter) stood at 0.51 in 2021, then decreased by 23.01% to 0.39 in 2022, then fell by 7.24% to 0.36 in 2023, then decreased by 16.48% to 0.3 in 2024, then skyrocketed by 31.09% to 0.4 in 2025.
  • Its Equity Ratio stands at 0.4 for Q3 2025, versus 0.41 for Q2 2025 and 0.41 for Q1 2025.